Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |